top of page

Congressional Neuroscience Caucus

The bipartisan Congressional Neuroscience Caucus promotes a better understanding of how the brain develops, functions, and ages.

Co-chaired by Representative Morgan Luttrell (R-TX) and Representative Mike Thompson (D-CA), the caucus seeks to raise awareness about the millions of Americans afflicted with neurological disorders or mental illnesses.

See if your Representative is a MEMBER of the Congressional Neuroscience Caucus, if they are not listed, we encourage you to ASK them to join today!

Announcing new Congressional Neuroscience Co-Chair ~ January 3, 2025

Representative Mike Thompson (D-CA) joined Representative Morgan Luttrell (R-TX) as Co-Chair of the bipartisan Congressional Neuroscience Caucus (CNC) for the 119th Congress. Rep. Thompson succeeds Representative Earl Blumenauer (D-OR), who co-founded the CNC in 2010 alongside Representative Cathy McMorris Rodgers (R-WA). View full press release here.

Congressional Neuroscience Caucus Briefings

The American Brain Coalition has teamed up with the Congressional Neuroscience Caucus in hosting and organizing events that focus on neuroscience: sponsoring briefings and information sessions on neuroscience research and findings; collaborating with patient advocacy, physician, and research organizations to build awareness; and distributing congressional communications and information such as Dear Colleagues and Congressional Record statements.

September 10, 2025 - Inventing the Future: Brain-Inspired Next-Generation Artificial Intelligence 
(View Recording) (View Summary)

  • Introductions & Moderator: John Ngai, Director, NIH BRAIN Initiative

  • Keynote Address: Former Representative Jennifer Wexton 

  • Mala Murthy, PhD, Director, Princeton Neuroscience Institute

  • Alex Leow, MD, PhD, Professor in Psychiatry & Bioengineering, University of Illinois Chicago

  • Leigh R. Hochberg, MD, PhD, Critical Care Neurologist & Neuroscientist, Massachusetts General Hospital, Brown University, and VA Providence Healthcare

  • Opening Remarks: Mark Rasenick, PhD, ABC Board Chair, Distinguished Professor of Physiology & Biophysics and Psychiatry, University of Illinois, Chicago

  • Introductions & Moderator: Walter J. Koroshetz, MD, Director, National Institute of Neurological Disorders & Stroke (NINDS)

  • Erika Augustine, MD, MS, Kennedy Krieger Institute

  • Richard Huganir, PhD, Johns Hopkins School of Medicine

  • Edward M. Kaye, MD, Stoke Therapeutics

  • Ilene Penn Miller, JD, Epilepsy Thought Leader

  • Opening Remarks: Mark Rasenick, PhD, ABC Board Chair, Distinguished Professor of Physiology & Biophysics and Psychiatry, University of Illinois, Chicago

  • John J. Ngai, PhD, Director, The NIH Brain Research Through Advancing Innovative Neurotechnologies (BRAIN) Initiative

  • Nora Volkow, MD, Director, National Institute on Drug Abuse (NIDA)

  • Edward Mowery, BRAIN Study Participant

  • Prasad Shirvalkar, MD, PhD, BRAIN Principal Investigator, Associate Professor, University of California, San Francisco

  • Paul J. Kenny, PhD, Director, Drug Discovery Institute, Professor & Chair, Neuroscience, Icahn School of Medicine at Mount Sinai

  • Opening Remarks: Mark Rasenick, PhD, ABC Board Chair, Distinguished Professor of Physiology & Biophysics and Psychiatry, University of Illinois, Chicago

  • John J. Ngai, PhD, Director, The NIH Brain Research Through Advancing Innovative Neurotechnologies (BRAIN) Initiative

  • Evan Einstein, MD, MPH, Psychiatrist, Assistant Professor, University of California, Los Angeles  

  • Adam Holbrook, Infantry Platoon Sergeant, US Army, E4/Specialist (Ret.)

  • Nanthia Suthana, PhD, Associate Professor, Department of Neurosurgery, University of California, Los Angeles

  • Moderator: Diane Lipscombe, PhD, Government & Public Affairs Committee Chair,
    Society for Neuroscience

bottom of page